Navigation Links
Masimo to Report Third Quarter 2008 Financial Results on October 27, 2008
Date:10/15/2008

Conference call and webcast to begin after markets close at 2:00 p.m. PT

(5:00 p.m. ET)

IRVINE, Calif., Oct. 15 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through-Motion- and-Low-Perfusion pulse oximetry, today announced it will release third quarter financial results for the period ended September 27, 2008 after the market closes on Monday, October 27, 2008.

A conference call to review the results will begin at 2:00 p.m. PT (5:00 p.m. ET) and will be hosted by Joe E. Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad, Executive Vice President and Chief Financial Officer.

A live webcast of the conference call will be available online from the investor relations page of the Company's corporate web site at http://www.masimo.com. The dial-in numbers are (800) 399-7902 for domestic callers and +1 (706) 634-0949 for international callers. The reservation number for both dial-in numbers is 68032269. After the live webcast, the call will remain available on Masimo's website through November 27, 2008. In addition, a telephonic replay of the call will be available until November 9, 2008. The replay dial-in numbers are (800) 642-1687 for domestic callers and +1 (706) 645-9291 for international callers. Please use reservation code 68032269.

About Masimo

Masimo (NASDAQ: MASI) develops innovative monitoring technologies that significantly improve patient care -- helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through-Motion-and-Low-Perfusion pulse oximetry, known as Masimo SET, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET Pulse CO-Oximetry, a breakthrough noninvasive blood constituent monitoring platform that can measure many blood constituents that previously required invasive procedures. Rainbow SET continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO(R)), methemoglobin (SpMet(R)), and PVI(TM), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI), allowing early detection and treatment of potentially life-threatening conditions. Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications." Additional information about Masimo and its products may be found at http://www.masimo.com.

Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications, Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Pulse CO-Oximetry and Pulse CO-Oximeter are trademarks or registered trademarks of Masimo Corporation.


'/>"/>
SOURCE Masimo Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors
2. Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices
3. Masimo to Present at Goldman Sachs 29th Annual Global Healthcare Conference
4. Masimo to Present at Deutsche Bank 33rd Annual Health Care Conference
5. Masimo Reports First Quarter 2008 Financial Results
6. Atom Medical Adopts Masimo Rainbow SET Technology
7. Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide
8. Masimo to Present at Citi Investment Research 5th Annual Small & Mid-Cap Conference
9. Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results
10. Masimo Announces Continuous Noninvasive Total Hemoglobin
11. Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... Resoundant, Inc. is ... imaging centers around the U.S. that offer MR Elastography for liver fibrosis staging. ... needle biopsy for staging liver fibrosis assessment. , “MRE:connect was created in response ...
(Date:7/20/2017)... 2017   KCNQ2 Cure Alliance  and ... today announced that they have completed the first ... implicated in KCNQ2 epileptic encephalopathy. They also report ... case involving an additional KCNQ2 genetic mutation. ... Pairnomix entered into a collaboration to further explore ...
(Date:7/18/2017)... ... July 18, 2017 , ... Genedata, a leading provider of ... technology company, has implemented Genedata Biologics ™ to scale-up their bispecific antibody ... and Neurodegenerative Diseases. , The need to systematically evaluate large panels of ...
(Date:7/17/2017)... ... July 17, 2017 , ... Whitehouse Laboratories is ... to encompass the full series of ISO 80369 standard test procedures. The ISO ... device and drug delivery systems. With this recent expansion, Whitehouse Labs becomes one ...
Breaking Biology Technology:
(Date:5/16/2017)... , May 16, 2017  Veratad Technologies, LLC ( ... online age and identity verification solutions, announced today they ... Conference 2017, May 15 thru May 17, 2017, in ... and International Trade Center. Identity impacts ... and in today,s quickly evolving digital world, defining identity ...
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
(Date:4/13/2017)... PUNE, India , April 13, 2017 According ... Identity Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication ... by MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 ... Annual Growth Rate (CAGR) of 17.3%. ... ...
Breaking Biology News(10 mins):